EPISODE · Mar 16, 2026 · 6 MIN
今天3分钟我们来聊聊全球首款干细胞抗衰药临床成果出炉
from 源于细胞BioInsid的个人播客
2026年2月，美国Longeveron公司宣布干细胞疗法2b期试验成功。老年患者接受治疗后，步行能力提升20%，炎症标志物下降。该疗法或改变老年虚弱症治疗格局，公司计划下半年启动新试验。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊全球首款干细胞抗衰药临床成果出炉
0:00
6:30
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 6 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on March 16, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!